These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 23997989)
21. Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism. Fernandes MS; Reddy MM; Croteau NJ; Walz C; Weisbach H; Podar K; Band H; Carroll M; Reiter A; Larson RA; Salgia R; Griffin JD; Sattler M J Biol Chem; 2010 Oct; 285(42):32596-605. PubMed ID: 20622007 [TBL] [Abstract][Full Text] [Related]
22. E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease. Bandi SR; Brandts C; Rensinghoff M; Grundler R; Tickenbrock L; Köhler G; Duyster J; Berdel WE; Müller-Tidow C; Serve H; Sargin B; Blood; 2009 Nov; 114(19):4197-208. PubMed ID: 19734451 [TBL] [Abstract][Full Text] [Related]
23. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Sehat B; Andersson S; Girnita L; Larsson O Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619 [TBL] [Abstract][Full Text] [Related]
24. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling. Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651 [TBL] [Abstract][Full Text] [Related]
25. The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies. Ren J; Lv L; Tao X; Zhai X; Chen X; Yu H; Zhao X; Kong X; Yu Z; Dong D; Liu J Front Pharmacol; 2024; 15():1432545. PubMed ID: 39130630 [TBL] [Abstract][Full Text] [Related]
26. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. Kassenbrock CK; Anderson SM J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950 [TBL] [Abstract][Full Text] [Related]
31. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme. Ryan PE; Sivadasan-Nair N; Nau MM; Nicholas S; Lipkowitz S J Biol Chem; 2010 Jul; 285(31):23687-98. PubMed ID: 20525694 [TBL] [Abstract][Full Text] [Related]
32. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. Sohn HW; Gu H; Pierce SK J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181 [TBL] [Abstract][Full Text] [Related]
33. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Thien CB; Langdon WY Biochem J; 2005 Oct; 391(Pt 2):153-66. PubMed ID: 16212556 [TBL] [Abstract][Full Text] [Related]
34. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677 [TBL] [Abstract][Full Text] [Related]
35. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609 [TBL] [Abstract][Full Text] [Related]
39. Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants. Chung BM; Tom E; Zutshi N; Bielecki TA; Band V; Band H World J Clin Oncol; 2014 Dec; 5(5):806-23. PubMed ID: 25493220 [TBL] [Abstract][Full Text] [Related]
40. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation. Kyo S; Sada K; Qu X; Maeno K; Miah SM; Kawauchi-Kamata K; Yamamura H Genes Cells; 2003 Oct; 8(10):825-36. PubMed ID: 14531861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]